Moderna Awarded $56 Million for Mobile Manufacturing of Nucleic Acid Vaccines and Therapeutics
- Posted by ISPE Boston
- On October 8, 2020
Moderna has received a commitment of up to $56 million from the Defense Advanced Research Projects Agency (DARPA) to fund the development of a mobile manufacturing protype that is capable of rapidly producing messenger RNA (mRNA) vaccines and therapeutics. The agreement builds on a previous assistance grant with DARPA established in 2013. The award is […]
Read More